This is a routine annual meeting with no surprises. Monitor the next 10-Q for any changes in financial guidance or business strategy, as this proxy filing itself does not signal any material shifts.
Price Chart
Executive Summary
Adaptive Biotechnologies (ADPT) is holding its 2026 annual shareholder meeting to vote on three key proposals: electing two new board members (Robert Hershberg and Katey Owen), approving executive compensation, and ratifying the appointment of Ernst & Young as the independent auditor. The board recommends a vote in favor of all proposals. This is a routine annual meeting with no activist involvement or contested votes.
Key Financial Metrics
Key Facts
- The filing is a definitive proxy statement (DEFA14A) for the 2026 annual shareholder meeting.
- Three proposals are on the ballot: electing two Class I directors, approving executive compensation, and ratifying the auditor.
- The board of directors recommends a 'FOR' vote on all proposals.
- The meeting will be held entirely online on June 5, 2026.
- There is no indication of an activist campaign or contested election; this is a standard annual meeting.
Financial Impact
This filing has no direct financial impact on the company's revenue, earnings, or debt. It is a procedural and governance document.
Risk Factors
- Low risk; the main risk is a low shareholder turnout, but this is typical for routine proxy votes.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-177421 |
| Document: 0001193125-26-177421-index-headers.html | 0001193125-26-177421 |
| Document: 0001193125-26-177421-index.html | 0001193125-26-177421 |
| Document: 0001193125-26-177421.txt | 0001193125-26-177421 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 6, 2026 20d ago | 144 | $26.28 | awaiting T+20 | — | $26.27 (−0.04%) |
Oct 5, 2026 21d ago | Insider Cluster | $26.90 | awaiting T+20 | — | $26.27 (−2.34%) |
Sep 25, 2026 4w ago | Press Release | $29.43 $25.51 | ▼ −13.32% | ▼ −11.84% | $26.27 (−10.74%) |
Sep 18, 2026 5w ago | Insider Cluster | $27.86 $23.95 | ▲ +14.03% | ▲ +13.13% | $26.27 (+5.71%) |
Aug 20, 2026 9w ago | Insider Cluster | $25.99 $27.86 | ▲ +7.20% | ▲ +7.72% | $26.27 (+1.08%) |
Aug 19, 2026 9w ago | Insider Cluster | $25.44 $28.55 | ▼ −12.22% | ▼ −12.22% | $26.27 (−3.26%) |
Aug 18, 2026 9w ago | 144 | $25.49 $26.68 | ▲ +4.67% | ▲ +6.19% | $26.27 (+3.06%) |
Aug 17, 2026 10w ago | 144 | $24.56 $27.67 | ▼ −12.66% | ▼ −13.97% | $26.27 (−6.96%) |
Jul 29, 2026 12w ago | Institutional Cluster | $24.18 $26.44 | ▼ −9.35% | ▼ −5.38% | $26.27 (−8.64%) |
Jul 23, 2026 13w ago | Insider Cluster | $22.27 $25.99 | ▲ +16.70% | ▲ +13.08% | $26.27 (+17.96%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers